Considering previous studies, which demonstrated that the combination of hyperammonemia and inflammation may be the key for the development of MHE [17,18], we aimed to investigate how hyperammonemia and high levels of inflammation may influence the plasma levels of NfL in MHE patients. The gene discussed is NEFL; the disease is Hyperammonemia.